0.00

100.00% -0.048

Io Biotech Inc (IOBT)

Overview News Price History Financials Discussions Forecast

Io Biotech Inc stock is traded at $0.00, with a volume of 0. It is down -100.00% in the last 24 hours and down -100.00% over the past month. IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.

Previous Close:

$0.048

Open:

24h Volume:

Relative Volume:

0.00

Market Cap:

$3.45M

Revenue:

Net Income/Loss:

$-88.35M

P/E Ratio:

0.00

EPS:

-1.3391

Net Cash Flow:

$-81.07M

1W Performance:

-100.00%

1M Performance:

-100.00%

6M Performance:

-100.00%

1Y Performance:

-100.00%

1-Day Range:

$0.00

1-Week Range:

$0.00

52-Week Range:

$0.00

$2.79

Io Biotech Inc Stock (IOBT) Company Profile

Name

Io Biotech Inc

Sector

Healthcare (1109)

Industry

Biotechnology (621)

Phone

(457) 070-2980

Address

OLE MAALOES VEH 3, COPENHAGEN

Employee

Twitter

Next Earnings Date

2026-05-13

Latest SEC Filings

IOBT's Discussions on Twitter

Compare IOBT vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
IOBT Io Biotech Inc	0.00	3.45M	0	-88.35M	-81.07M	-1.3391
VRTX Vertex Pharmaceuticals Inc	444.93	112.92B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	612.14	64.18B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	893.52	55.57B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	282.85	37.76B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	153.87	32.71B	742.00K	-1.37B	-1.07B	-7.0731

Io Biotech Inc Stock (IOBT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-26-26	Downgrade	Piper Sandler	Overweight → Neutral
Jan-08-26	Downgrade	Morgan Stanley	Equal-Weight → Underweight
Sep-30-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Sep-30-25	Downgrade	TD Cowen	Buy → Hold

Io Biotech Inc Stock (IOBT) Latest News

Jun 11, 2026

Fierce Biotech Layoff Tracker 2026: Genentech trims R&D; Fulcrum shrinks headcount 85% - Fierce Biotech

Jun 11, 2026

Jun 08, 2026

IO Biotech (IOBT) common stock removed from Nasdaq in voluntary withdrawal - Stock Titan

Jun 08, 2026

Layoff Tracker: Fulcrum axes 85% of staff after walking away from lead asset - BioSpace

Jun 08, 2026

Jun 02, 2026

Major IO Biotech (IOBT) shareholder updates 27.4% stake as company enters Chapter 7 - Stock Titan

Jun 02, 2026

May 27, 2026

IOBTQ Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

May 27, 2026

May 26, 2026

IO Biotech (IOBT) Holds Steady at $0.05 as Key Support and Resistance ConvergeTrend Continuation Trade - The Legal Advocate

May 26, 2026

May 25, 2026

IO Biotech Q3 2025 Earnings: EPS Beat of 60.67% Surprise, but No Revenue from Pre-Commercial PipelineEstimate Revision Count - The Legal Advocate

May 25, 2026

May 23, 2026